BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31846626)

  • 1. The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients.
    Song J; Du G; Chen W; Bao P; Li B; Lu Q; Shi B
    Eur J Pharmacol; 2020 Feb; 869():172872. PubMed ID: 31846626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus.
    Song J; Xiao L; Du G; Gao Y; Chen W; Yang S; Fan W; Shi B
    Int Immunopharmacol; 2016 Sep; 38():90-6. PubMed ID: 27258186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
    Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
    Front Immunol; 2021; 12():716559. PubMed ID: 34335631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients.
    Gong N; Chen Z; Wang J; Fang A; Li Y; Xiang Y; Ming C; Zhang W
    Cell Immunol; 2015 Oct; 297(2):87-93. PubMed ID: 26205091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients.
    Ibrahim EH; Aly M; Morath C; Sayed DM; Ekpoom N; Opelz G; Süsal C; Daniel V
    Immun Inflamm Dis; 2021 Dec; 9(4):1252-1271. PubMed ID: 34102006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.
    Ghazal K; Stenard F; Dahlqvist G; Barjon C; Aoudjehane L; Scatton O; Conti F
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):237-244. PubMed ID: 29175009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
    Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
    Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher CD19+CD25
    Ibrahim EH; Aly MG; Opelz G; Morath C; Zeier M; Süsal C; Sayed DM; Hassan E; Ekpoom N; Daniel V
    BMC Nephrol; 2021 May; 22(1):180. PubMed ID: 33993874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia.
    Dong Q; Li G; Fozza C; Wang S; Yang S; Sang Y; Liu X; Chen C
    Biomed Res Int; 2020; 2020():7023168. PubMed ID: 33083479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease.
    Yuksel M; Nazmi F; Wardat D; Akgül S; Polat E; Akyildiz M; Arikan Ç
    Front Immunol; 2022; 13():1053216. PubMed ID: 36685568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status.
    Song JY; Du GS; Xiao L; Chen W; Suo LL; Gao Y; Feng LK; Shi BY
    Chin Med J (Engl); 2016 Jun; 129(11):1340-6. PubMed ID: 27231173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral T and B lymphocytes in patients with occupational medicamentosa-like dermatitis due to trichloroethylene].
    Deng LD; Deng LH; Lin DF; Tang HY; Wang DP; Luo B; Tong XD; Zhang W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Oct; 38(10):731-735. PubMed ID: 33142373
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
    Mittal SK; Sharma RK; Gupta A; Naik S
    Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Wang X; Wang W; Xu J; Hong J; Le Q
    Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.